Fibromyalgia severity and symptoms are associated with the disorders of gut–brain interaction

Sharon Erdrich,Joanna E. Harnett
DOI: https://doi.org/10.1002/ejp.4766
2024-12-14
European Journal of Pain
Abstract:Introduction Fibromyalgia remains an idiopathic common disorder characterised by widespread pain with no universally accepted treatment. Irritable bowel syndrome is prevalent among women living with fibromyalgia. The prevalence of other disorders of gut–brain interaction (DGBI) and associations with fibromyalgia symptoms and severity is unknown. Objectives To evaluate the prevalence of the range of DGBI and associations with the symptoms and severity of fibromyalgia in women. Methods A prospective observational study was conducted in New Zealand in 2022. A comprehensive survey included validated measures to identify DGBI (Rome IV) and items assessing the severity of fibromyalgia and pain symptoms, sleep quality, quality of life, mental health and migraine. Analysis was conducted employing Spearman's rho, Mann–Whitney U, Kruskal–Wallis and chi‐square tests. Results A total of 111 adult women with fibromyalgia enrolled in the study. Of these, 98 (93%) met the criteria for at least one DGBI, and 67 (68%) satisfied criteria for more than one. All groups of DGBI, and 11 specific DGBI were significantly associated with measures of pain, fibromyalgia severity, sleep problems and migraine (p
neurosciences,clinical neurology,anesthesiology
What problem does this paper attempt to address?